Product Name :
Anti-HIV-1 gp120 V3(Zinlirvimab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
HIV-1 gp120 V3
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-HIV-1 gp120 V3(Zinlirvimab Biosimilar) Antibody is a biosimilar antibody directed against HIV-1 gp120 V3. | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: HIV-1 gp120 V3 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.{{1613509-49-1} medchemexpress|{1613509-49-1} Biological Activity|{1613509-49-1} Data Sheet|{1613509-49-1} manufacturer} 5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-HIV-1 gp120 V3(Zinlirvimab Biosimilar) Antibody is a biosimilar antibody directed against HIV-1 gp120 V3.{{1229022-83-6} web|{1229022-83-6} Biological Activity|{1229022-83-6} Data Sheet|{1229022-83-6} custom synthesis}
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.PMID:31234717 Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.